Articles tagged with Cancer Treatments
T-ALL is caused by interplay of various factors including genetic errors that disrupt white blood cell formation. The study identifies PTPN2 as a tumor suppressor gene lost in leukemia patients, contributing to cancerous cell proliferation.
Researchers found that females receiving CRT-D therapy had a 70% reduction in heart failure progression and a 72% reduction in death from any cause. Men received some benefit, but not the out-of-the-park results seen in women.
Melanoma cells can self-renew and induce new tumors, defying the traditional cancer stem cell model. Targeting both bulk tumor cells and slow-growing JARID1B-positive subpopulations is proposed as a dual therapy to combat therapy resistance.
A study in fruit flies reveals a molecular pathway involved in dietary choices, which has implications for humans sharing the same pathway. The research opens doors to developing treatments for metabolic disorders by addressing nutritional imbalances.
The cost of cancer treatment in the US has nearly doubled over the past two decades, with private insurance and Medicaid bearing a growing burden. Inpatient hospital admissions account for a smaller share of costs, while outpatient expenditures increase.
Elderly patients with localized kidney cancer may benefit from conservative care, such as observation or treatments that spare the noncancerous parts of their kidneys. The study found no significant difference in survival rates between those who had their entire kidney removed and those who received active monitoring.
Special issue of Journal of the American College of Cardiology explores controversy surrounding cardiac imaging tests. Experts call for balance between risks and benefits, emphasizing that these tests should only be used when clinical benefit exceeds potential harm.
Research finds common intestinal bacteria promote tumor growth in genetically susceptible mice, but an inhibiting protein enzyme suppresses growth, increasing survival time. The study's findings could lead to a new form of treatment for familial adenomatous polyposis, a genetic condition that increases the risk of colon cancer.
A recent study published in the journal Surgery found that mechanical bowel preparations (MBPs) do not reduce perioperative infectious complications in patients undergoing pancreaticoduodenectomy. The researchers analyzed data from over 200 patients and concluded that MBPs have no clinical benefit for this procedure.
Researchers developed a simple genetic test using three genes to classify breast cancer into sub-types, highlighting the importance of molecular classification in treatment outcomes. The study's findings suggest that these models are robust and can aid clinicians in making therapeutic decisions.
Scientists developed a multistage nanovector system to deliver siRNA, significantly lengthening the therapeutic effects of treatment in mouse models of ovarian cancer. The system provides sustained delivery of siRNA for up to three weeks, targeting the EphA2 oncoprotein.
Researchers have made significant advancements in diagnosing and treating Barrett's esophagus and inflammatory bowel disease. A new study found that endoscopic radiofrequency ablation can effectively eliminate the condition in most instances, with five-year durability outcomes showing 46 of 50 patients remained free of disease.
A new national survey found that public support for nanotechnology increases when informed of its risks alongside benefits. However, discussing risks decreased support among those who had never heard of nanotechnology before the survey.
Researchers found that pre-treatment quality-of-life scores can predict malignancy in patients with pancreatic lesions and survival in those who have cancer. Patients with lower quality-of-life scores were more likely to have poor survival rates.
A new study published in the Journal of the American College of Surgeons found that more than 90% of breast cancer patients had their expectations met or exceeded with regard to dates of service. The study highlights the importance of balancing timeliness with safety, effectiveness and equity in patient satisfaction.
A study suggests that preoperative breast MRI can reduce local breast cancer recurrences at follow-up, particularly in young patients with dense breast tissue. The study found that patients who received a contrast-enhanced MRI prior to surgery had significantly fewer local recurrence cases.
The National Cancer Institute Alliance for Nanotechnology in Cancer is making significant progress, promising earlier disease diagnosis, targeted treatments, and improved survival rates.
A recent review found that approximately 25% of breast cancers and 60% of prostate cancers detected by screening tests may not be destined to cause symptoms or death due to overdiagnosis. This phenomenon leads to unnecessary treatment and other harms, emphasizing the need for strategies to address it.
Research found a strong correlation between heavy alcohol use and shortened telomeres, increasing cancer risk. Telomere length was nearly half as long in heavy drinkers compared to non-abusers.
Researchers found elevated EGFR levels in blood of women with breast cancer 17 months prior to diagnosis, increasing risk by 2.9-fold. This marker shows promise as an early detection biomarker for breast cancer.
A systematic review of 111 studies involving 4,394 patients found that a third could undergo resection after neoadjuvant therapy, with similar survival rates to those judged resectable before treatment. The study suggests including locally advanced/unresectable tumors in neoadjuvant protocols.
Researchers at Fox Chase Cancer Center have identified NEDD9 as a key molecular player in the formation of HER2-driven breast tumors. The study shows that mice with the Nedd9 gene are more likely to develop tumors over an 18-month period, highlighting the protein's potential as a biomarker.
Scientists have discovered that Rho GDI1 plays a crucial role in balancing the levels of other Rho proteins, which are involved in cell migration, proliferation, and death. This finding may lead to new therapies targeting the balance of these proteins to prevent cancer.
Researchers have evaluated a blood test that identifies patients with low-grade, low-stage prostate cancer who are at risk of needing treatment. The study found that a biomarker called Prostate Health Index was significant in predicting unfavorable biopsy conversion.
A blood test and DNA analysis accurately predict which men with low-grade prostate cancers may need treatment, say Johns Hopkins scientists. The prostate health index and DNA content in biopsy tissue can detect the progression of small prostate cancers.
The study demonstrates a potential new treatment paradigm in oncology with improved overall survival rates for metastatic castration-resistant prostate cancer patients. The treatment, Sipuleucel-T, was shown to have well-balanced prognostic factors and mild adverse events.
Patient advocates and researchers at Vanderbilt Ingram Cancer Center presented an interactive game show on cancer research to increase awareness, particularly of clinical trials. The event resulted in a 20% increase in participants' knowledge and high engagement rates.
Research reveals higher breast cancer rates among Latinas due to early diagnosis and poorer outcomes. Studies also show significant disparities in healthcare access and knowledge about screening practices among Mexican and Latina women living in the US.
The EORTC 30904 study found that conservative surgery is not inferior to radical renal surgery or nephrectomy, with a slightly higher complication rate. Overall survival rates were shorter on the conservative arm for all randomized patients, but not different for RCC or clinically/pathologically eligible patients.
A new study found a link between chronic HBV and progression to cancers other than hepatocellular carcinoma, specifically Non-Hodgkin Lymphoma (NHL) and Cholangiocarcinoma. Higher levels of viral replication were associated with increased risk, indicating a potential causal effect.
A large patient cohort study found that genomic-based portraits can predict liver cancer recurrence. Two gene signatures were identified to identify patients with poor disease outcomes, enabling preventive therapies. The study also highlights potential therapeutic targets for adjuvant treatment following surgical intervention.
Researchers identified childhood cancer survivors at increased risk for deteriorating lung health due to bone marrow transplants. Long-term monitoring and early intervention, as well as educating high-risk patients on avoiding tobacco smoke and air pollution, are recommended to prevent respiratory problems.
Researchers discovered a network of genes responsible for initiating and managing primary cilia formation. The study may lead to new therapies for ciliopathies, a group of genetic diseases caused by defects in primary cilia function or structure.
New data presented at the American Academy of Neurology annual meeting showed that patients with moderate to severe RLS using rotigotine achieved sustained improvements in symptoms over 5 years. The study confirmed the safety and efficacy of rotigotine, with over a third of patients remaining symptom-free after 5 years.
A study published in The Lancet Oncology found that men with prostate cancer are at increased risk of potentially life-threatening blood clots. Patients receiving endocrine therapy had the highest risk, especially younger men and those with advanced disease.
Researchers at the University of Texas M. D. Anderson Cancer Center have developed a new way to predict prognosis in pediatric leukemia patients using a common complete blood count test. The study found that combining the minimal residual disease indicator and absolute lymphocyte count provides better results than MRD alone, identifyin...
Researchers at UEA have discovered a new group of molecules that can inhibit glycosyltransferases, enzymes used by cells to create sugar chains. This breakthrough could lead to significant advances in cancer treatment and therapy.
Sudden sensorineural hearing loss (SSNHL) affects one ear, often associated with tinnitus and vertigo. Short-course corticosteroids are recommended for patients with suspected SSNHL after ruling out life-threatening causes.
Researchers at Van Andel Research Institute have identified key proteins involved in the development of prostate cancer. Understanding their interaction could lead to more effective treatments by targeting this molecular link.
A new study published in the Journal of Thoracic Oncology found that sleeve lobectomy offers superior survival and better postoperative pulmonary function compared to pneumonectomy in selected patients. The study analyzed 210 lung cancer patients and reported lower mortality rates for those who underwent a sleeve lobectomy.
Researchers found that certain buckyball configurations, such as the tris configuration, caused premature senescence in human skin cells. This could lead to disease development if not properly understood. The study provides early foundations for worker protection and highlights the need for federal regulations on nanomaterial use.
Rylander aims to create a multi-component treatment planning computational model for nanoparticle-medicated laser therapy to achieve selective and effective cancer treatment. She will also develop a course on nanotherapeutics and establish an education and outreach plan for underprivileged schools.
A pilot study reveals that many children with cancer enrolled in clinical trials do not fully comprehend their treatment options or feel involved in decision-making. The study's findings underscore the importance of clearer communication between physicians and patients.
A recent meta-analysis of 14 trials found that pregnancy after breast cancer diagnosis reduces the risk of death by 42%. The study suggests that hormonal changes during pregnancy may have an inhibitory effect on breast cancer cells, and that foetal antigens may also play a role in reducing the risk of recurrence. The findings support t...
Researchers at EPFL discovered how tumors create a tolerant microenvironment by mimicking key features of lymph nodes. This allows tumors to avoid detection by the immune system, leading to cancer progression.
St. Jude Children's Research Hospital investigators have identified a protein that plays a pivotal role in protecting the intestinal tract from colitis. The Nlrp3 protein helps maintain healthy colon function by triggering production of epithelial cells to compensate for damage caused by colitis.
Disabling the Skp2 gene after oncogenic stress induces cellular senescence in cancer cells, restricting tumor growth. Researchers believe this could lead to novel agents that suppress tumor development in common types of cancer.
A study found that case management in the National Breast and Cervical Cancer Early Detection Program reduced delays in diagnosis among low-income women by 45% between 1998 and 2007. Free treatment also showed no significant impact on diagnostic or treatment delays.
Researchers at UAB found that Gardasil vaccine reduces the likelihood of HPV-related disease recurring after surgery by approximately 40 percent. This protection can provide crucial follow-up care and overall health planning for teens and women.
Researchers at the University of Leicester have made a new discovery about how the body fights certain types of cancer and autoimmune diseases. A newly discovered protein, HVCN1, regulates antibody production and can be targeted for therapies to treat conditions like lupus and rheumatoid arthritis.
Researchers have found that a seaweed extract has an inhibitory effect on the growth of non-Hodgkin's lymphoma cell lines. The extract also showed a significant pattern of activity in genes linked to apoptosis, or cell death, in lymphoma cells.
A recent study has found that breast cancer is affecting premenopausal women in Iraq, with a significant proportion presenting with advanced stage cancer. The study also highlights the importance of early detection and treatment, as only 32% of women detected a lump on self-examination sought medical advice within the first month.
Researchers have detected a novel oncolytic viral therapy against prostate cancer using the reovirus, showing safety and efficacy in early-stage patients. The study found that the virus induced cancer cell death without replicating in normal tissues, with minimal toxicity reported.
A new study finds that cancer death rates have decreased significantly since the initiation of the 'war on cancer', resulting in a decline of 21% in men and 12% in women. For individuals under 75, this drop translates to approximately 2 million years of potential life gained.
Researchers identified IFN-beta as a natural inhibitor of tumor blood vessel growth, limiting tumor growth and immune cell gene expression. This discovery provides insight into why IFN therapy benefits early cancer development.
A study published in Cell reveals that loss of the molecule miR-328 is essential for progression from chronic to blast crisis phase in chronic myeloid leukemia. Maintaining this microRNA level may represent a new treatment strategy for CML blast crisis patients.
Researchers found that lung cancer patients with optimistic attitudes had a six-month survival advantage over those with pessimistic attitudes. This study builds on existing research to investigate the effect of patient attitudes on outcomes in oncology populations.
A new evaluation tool helps clinicians decide whether to surgically remove or monitor asymptomatic pancreatic cysts. The tool considers overall health, age, cyst size, surgical risk, and patients' quality of life preferences.
Researchers found that bitter melon extract significantly decreased proliferation and induced death in breast cancer cells. The study suggests that this extract may become a chemopreventive agent against breast cancer, but additional studies are needed to confirm its efficacy.
Researchers have identified five SIBLING proteins that can predict oral cancer development in premalignant lesions. The study found that certain SIBLINGs, such as dentin sialophosphoprotein, increase the risk of oral cancer fourfold, while others, like bone sialoprotein, significantly decrease it.